INCYTE CORPORATION Investment Income, Net
INCYTE CORPORATION (INCY) reported Investment Income, Net of $31.76 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-14.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2019-02-14
- INCYTE CORPORATION investment income, net for the quarter ending 2017-12-31 was $6.27M, a 955.39% increase year-over-year.
- INCYTE CORPORATION investment income, net for the quarter ending 2017-09-30 was $5.55M, a 367.59% increase year-over-year.
- INCYTE CORPORATION investment income, net for the quarter ending 2017-06-30 was $4.13M, a 262.80% increase year-over-year.
- INCYTE CORPORATION investment income, net for the quarter ending 2017-03-31 was $1.20M, a 19.30% decline year-over-year.
- INCYTE CORPORATION investment income, net for fiscal 2018 was $31.76M, a 85.16% increase from fiscal 2017.
- INCYTE CORPORATION investment income, net for fiscal 2017 was $17.15M, a 288.78% increase from fiscal 2016.
- INCYTE CORPORATION investment income, net for fiscal 2016 was $4.41M, a 37.76% decline from fiscal 2015.
- INCYTE CORPORATION investment income, net for fiscal 2015 was $7.09M, a 111.61% increase from fiscal 2014.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month | Investment Income, Net 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | $31.76M 10-K · filed 2019-02-14 | ||||
| 2017-12-31 | $6.27M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $11.82M derived: sum of 2 quarters · filed 2019-02-14 | $15.95M derived: sum of 3 quarters · filed 2019-02-14 | $17.15M 10-K · filed 2019-02-14 | $17.50M 10-K · filed 2018-02-15 |
| 2017-09-30 | $5.55M 10-Q · filed 2017-10-31 | $9.68M derived: sum of 2 quarters · filed 2017-10-31 | $10.88M 10-Q · filed 2017-10-31 | $11.48M derived: sum of 4 quarters · filed 2019-02-14 | |
| 2017-06-30 | $4.13M 10-Q · filed 2017-08-01 | $5.33M 10-Q · filed 2017-08-01 | $5.92M derived: sum of 3 quarters · filed 2019-02-14 | $7.11M derived: sum of 4 quarters · filed 2019-02-14 | |
| 2017-03-31 | $1.20M 10-Q · filed 2017-05-04 | $1.80M derived: sum of 2 quarters · filed 2019-02-14 | $2.99M derived: sum of 3 quarters · filed 2019-02-14 | $4.12M derived: sum of 4 quarters · filed 2019-02-14 | |
| 2016-12-31 | $594.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $1.78M derived: sum of 2 quarters · filed 2019-02-14 | $2.92M derived: sum of 3 quarters · filed 2019-02-14 | $4.41M 10-K · filed 2019-02-14 | |
| 2016-09-30 | $1.19M 10-Q · filed 2017-10-31 | $2.33M derived: sum of 2 quarters · filed 2017-10-31 | $3.82M 10-Q · filed 2017-10-31 | $5.11M derived: sum of 4 quarters · filed 2018-02-15 | |
| 2016-06-30 | $1.14M 10-Q · filed 2017-08-01 | $2.63M 10-Q · filed 2017-08-01 | $3.92M derived: sum of 3 quarters · filed 2018-02-15 | $6.94M derived: sum of 4 quarters · filed 2018-02-15 | |
| 2016-03-31 | $1.49M 10-Q · filed 2017-05-04 | $2.78M derived: sum of 2 quarters · filed 2018-02-15 | $5.81M derived: sum of 3 quarters · filed 2018-02-15 | $6.95M derived: sum of 4 quarters · filed 2018-02-15 | |
| 2015-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $4.32M derived: sum of 2 quarters · filed 2018-02-15 | $5.46M derived: sum of 3 quarters · filed 2018-02-15 | $7.09M 10-K · filed 2018-02-15 | |
| 2015-09-30 | $3.03M 10-Q · filed 2016-11-01 | $4.17M derived: sum of 2 quarters · filed 2016-11-01 | $5.80M 10-Q · filed 2016-11-01 | $6.74M derived: sum of 4 quarters · filed 2017-02-14 | |
| 2015-06-30 | $1.14M 10-Q · filed 2016-08-09 | $2.77M 10-Q · filed 2016-08-09 | $3.71M derived: sum of 3 quarters · filed 2017-02-14 | $4.60M derived: sum of 4 quarters · filed 2017-02-14 | |
| 2015-03-31 | $1.63M 10-Q · filed 2016-05-09 | $2.57M derived: sum of 2 quarters · filed 2017-02-14 | $3.46M derived: sum of 3 quarters · filed 2017-02-14 | $4.25M derived: sum of 4 quarters · filed 2017-02-14 | |
| 2014-12-31 | $940.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $1.82M derived: sum of 2 quarters · filed 2017-02-14 | $2.62M derived: sum of 3 quarters · filed 2017-02-14 | $3.35M 10-K · filed 2017-02-14 | |
| 2014-09-30 | $885.00K 10-Q · filed 2015-11-03 | $1.68M derived: sum of 2 quarters · filed 2015-11-03 | $2.41M 10-Q · filed 2015-11-03 | $2.90M derived: sum of 4 quarters · filed 2016-02-12 | |
| 2014-06-30 | $790.00K 10-Q · filed 2015-08-04 | $1.53M 10-Q · filed 2015-08-04 | $2.02M derived: sum of 3 quarters · filed 2016-02-12 | $2.40M derived: sum of 4 quarters · filed 2016-02-12 | |
| 2014-03-31 | $735.00K 10-Q · filed 2015-04-30 | $1.23M derived: sum of 2 quarters · filed 2016-02-12 | $1.61M derived: sum of 3 quarters · filed 2016-02-12 | $1.86M derived: sum of 4 quarters · filed 2016-02-12 | |
| 2013-12-31 | $495.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $880.00K derived: sum of 2 quarters · filed 2016-02-12 | $1.13M derived: sum of 3 quarters · filed 2016-02-12 | $1.32M 10-K · filed 2016-02-12 | |
| 2013-09-30 | $385.00K 10-Q · filed 2014-10-30 | $630.00K derived: sum of 2 quarters · filed 2014-10-30 | $829.00K 10-Q · filed 2014-10-30 | $1.20M derived: sum of 4 quarters · filed 2015-02-17 | |
| 2013-06-30 | $245.00K 10-Q · filed 2014-07-31 | $444.00K 10-Q · filed 2014-07-31 | $815.00K derived: sum of 3 quarters · filed 2015-02-17 | $842.00K derived: sum of 4 quarters · filed 2015-02-17 | |
| 2013-03-31 | $199.00K 10-Q · filed 2014-05-01 | $570.00K derived: sum of 2 quarters · filed 2015-02-17 | $597.00K derived: sum of 3 quarters · filed 2015-02-17 | $912.00K derived: sum of 4 quarters · filed 2015-02-17 | |
| 2012-12-31 | $371.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $398.00K derived: sum of 2 quarters · filed 2015-02-17 | $713.00K derived: sum of 3 quarters · filed 2015-02-17 | $764.00K 10-K · filed 2015-02-17 | |
| 2012-09-30 | $27.00K 10-Q · filed 2013-10-31 | $342.00K derived: sum of 2 quarters · filed 2013-10-31 | $393.00K 10-Q · filed 2013-10-31 | $607.00K derived: sum of 4 quarters · filed 2014-02-21 | |
| 2012-06-30 | $315.00K 10-Q · filed 2013-08-01 | $366.00K 10-Q · filed 2013-08-01 | $580.00K derived: sum of 3 quarters · filed 2014-02-21 | $625.00K derived: sum of 4 quarters · filed 2014-02-21 | |
| 2012-03-31 | $52.00K 10-Q · filed 2013-05-02 | $265.00K derived: sum of 2 quarters · filed 2014-02-21 | $310.00K derived: sum of 3 quarters · filed 2014-02-21 | $442.00K derived: sum of 4 quarters · filed 2014-02-21 | |
| 2011-12-31 | $213.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $258.00K derived: sum of 2 quarters · filed 2014-02-21 | $390.00K derived: sum of 3 quarters · filed 2014-02-21 | $462.00K 10-K · filed 2014-02-21 | |
| 2011-09-30 | $45.00K 10-Q · filed 2012-11-01 | $177.00K derived: sum of 2 quarters · filed 2012-11-01 | $249.00K 10-Q · filed 2012-11-01 | $1.12M derived: sum of 4 quarters · filed 2013-02-21 | |
| 2011-06-30 | $132.00K 10-Q · filed 2012-08-03 | $204.00K 10-Q · filed 2012-08-03 | $1.07M derived: sum of 3 quarters · filed 2013-02-21 | $1.28M derived: sum of 4 quarters · filed 2013-02-21 | |
| 2011-03-31 | $72.00K 10-Q · filed 2012-04-26 | $939.00K derived: sum of 2 quarters · filed 2013-02-21 | $1.15M derived: sum of 3 quarters · filed 2013-02-21 | $1.29M derived: sum of 4 quarters · filed 2013-02-21 | |
| 2010-12-31 | $867.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $1.08M derived: sum of 2 quarters · filed 2013-02-21 | $1.22M derived: sum of 3 quarters · filed 2013-02-21 | $1.42M 10-K · filed 2013-02-21 | |
| 2010-09-30 | $212.00K 10-Q · filed 2011-10-27 | $354.00K derived: sum of 2 quarters · filed 2011-10-27 | $549.00K 10-Q · filed 2011-10-27 | ||
| 2010-06-30 | $142.00K 10-Q · filed 2011-07-28 | $338.00K 10-Q · filed 2011-07-28 | |||
| 2010-03-31 | $195.00K 10-Q · filed 2011-05-03 | ||||
| 2009-12-31 | $50.00K 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |